General Information
Revision date
2019-07-01
Product name
Dacomitinib, Free Base
CAS No.
1110813-31-4
Icons in SDS
Company Information
company name
LC Laboratories
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302+H312+H332
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
Hazard statements
pharmaceutically active substance that has not been fully tested May be harmful if swallowed, inhaled, or absorbed through the skin Ingestion may result in diarrhea, dehydration, acneiform rash, dry skin, stomatitis/mucositis (inflammation/ulceration of the mucous membranes lining of the mouth and digestive tract), fatigue, and palmar–plantar erythrodysesthesia (also known as hand-foot syndrome manifested as redness, tenderness, peeling, blistering and ulceration of the palms and soles) Exposure may cause irritation of the skin, eyes, mucous membranes, and upper respiratory tract H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled
Precautionary statements
P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only
